Seven people have died in the US and three others have been left disabled after treatment with an anti-Alzheimer's drug

A drug for the treatment of Alzheimer's disease, recently approved in the United States, is under investigation after it was allegedly associated with seven deaths and several serious side effects, including cases of permanent disability. The controversial product is not yet authorized in Europe, and the European Medicines Agency previously rejected its application for marketing, citing significant risks to patients.